Management of non-retroperitoneal residual germ cell tumor masses.

Abstract

The appropriate management of residual disease outside of the retroperitoneum after chemotherapy is a critical component of the comprehensive approach to treating advanced testicular germ cell tumors (GCTs). Although some data suggest that certain variables (eg, histology at retroperitoneal lymph node dissection) can accurately predict non-retroperitoneal… (More)

Topics

Cite this paper

@article{Katz2007ManagementON, title={Management of non-retroperitoneal residual germ cell tumor masses.}, author={Mark H. Katz and James McKiernan}, journal={The Urologic clinics of North America}, year={2007}, volume={34 2}, pages={235-43; abstract x} }